Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

Simard J, Dumont M, Moisan A-M, et al. (including Joly Y), “Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer” 44:2 (2007) Journal of Medical Genetics, 107-121.

This content has been updated on July, 23 2024 at 15 h 20 min.